Welcome to Paid Research Studies

  • Conditions:   Mycobacterium Avium Complex;   Nontuberculous Mycobacterium Infection
    Interventions:   Drug: Azithromycin;   Drug: Ethambutol;   Drug: Rifampin
    Sponsors:   Kevin Winthrop;   Patient-Centered Outcomes Research Institute;   National Jewish Health;   The University of Texas Health Science Center at Tyler;   University Health Network, Toronto;   New York University;   Medical University of South Carolina;   Mayo Clinic;   Georgetown University;   University of Chicago;   Louisiana State University Health Sciences Center in New Orleans;   University of California, San Diego;   Stanford University;   University of Kansas;   Vancouver Clinic;   University of California, San Francisco;   University of Washington;   Johns Hopkins University;   University of Miami;   Emory University;   University of Iowa;   University of North Carolina;   Yale University;   Temple University;   Loma Linda University;   Columbia University;   University of Wisconsin, Madison

  • Condition:   HIV Infections
    Interventions:   Drug: atazanavir/cobicistat;   Drug: darunavir/ritonavir;   Drug: darunavir/cobicistat;   Drug: etravirine;   Drug: elvitegravir/cobicistat;   Drug: dolutegravir;   Drug: tenofovir alafenamide fumarate (TAF);   Drug: TAF/cobicistat;   Drug: TAF/ritonavir;   Drug: efavirenz;   Drug: lopinavir/ritonavir;   Drug: nevirapine;   Drug: rifampicin;   Drug: ethambutol;   Drug: isoniazid;   Drug: pyrazinamide;   Drug: kanamycin;   Drug: amikacin;   Drug: capreomycin;   Drug: moxifloxacin;   Drug: levofloxacin;   Drug: ofloxacin;   Drug: ethionamide/prothionamide;   Drug: terizidone/cycloserine;   Drug: para-aminosalicylic acid (PAS);   Drug: high dose isoniazid (INH);   Drug: bedaquiline;   Drug: clofazamine;   Drug: delamanid;   Drug: linezolid;   Drug: pretomanid;   Drug: atazanavir/ritonavir/tenofovir;   Drug: ethinyl estradiol oral contraceptive;   Drug: etonogestrel implant
    Sponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

  • Condition:   Tuberculosis, Pulmonary
    Interventions:   Drug: Azacitidine Injection [Vidaza] - Phase A Group;   Drug: Azacitidine Injection [Vidaza] - Phase B Group;   Drug: Azacitidine Injection [Vidaza] - Phase C Group;   Drug: Azacitidine Injection [Vidaza] - Phase D Group
    Sponsors:   Andrew Dinardo;   Celgene Corporation
    Not yet recruiting